CD73-IN-12
CD73-IN-12 is a potent inhibitor of CD73. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-12 be used for preparing a medicament for tumor-related diseases (extracted from patent CN114437038A, compound 9) [1]. CD73-IN-12 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Product Specifications
CAS Number
2773502-79-5
UNSPSC
12352005
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cd73-in-12.html
Solubility
10 mM in DMSO
Smiles
O=C1NC=C(C(N1)=O)C2=NN=C(C([C@@H]3C[C@H]3C(F)F)=C2)C#CC4CC4
Molecular Formula
C17H14F2N4O2
Molecular Weight
344.32
References & Citations
[1]Xuejun Zhang, et al. Pyridazine alkyne compound and application thereof. Patent CN114437038A.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
DDX41 (DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 41, ABS, MGC8828) (APC)
Diubiquitin/UBD Rabbit Polyclonal Antibody (FITC)
